Kobayashi Pharmaceutical Co (TSE:4967) EV-to-EBIT : 22.36 (As of May. 27, 2025)

Kobayashi Pharmaceutical Co EV-to-EBIT Chart

Kobayashi Pharmaceutical Co Annual Data
	Trend	Mar15	Mar16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					33.46	21.49	20.83	15.44	28.56

Kobayashi Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															12.41	17.52	27.19	28.56	-

Competitive Comparison of Kobayashi Pharmaceutical Co's EV-to-EBIT

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kobayashi Pharmaceutical Co's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's EV-to-EBIT falls into.

Kobayashi Pharmaceutical Co EV-to-EBIT Calculation

Kobayashi Pharmaceutical Co's EV-to-EBIT for today is calculated as:

Kobayashi Pharmaceutical Co's current Enterprise Value is 円315,316 Mil.
Kobayashi Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14,099 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co  (TSE:4967) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Kobayashi Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Kobayashi Pharmaceutical Co's Enterprise Value for the quarter that ended in Dec. 2024 was 円398,237 Mil.
Kobayashi Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14,099 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co Business Description